*Correspondence: Baptist Gallwitz, [email protected] This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
You can find out more about our use of cookies in our Privacy Policy
How do GLP-1 Receptor Agonists Work
What factors should we weigh in our consideration of the utility of GLP-1 agonists
A recent study demonstrated that in mice somatostatin and glucagon secretion are linked in a reciprocal feedback cycle with somatostatin inhibiting glucagon secretion at low and high glucose levels, and glucagon stimulating somatostatin secretion via the glucagon and GLP-1 receptors
Skovs S, Panzhinskiy E, Kolic J, et al